Laplace Interventional™ Announces First Patients treated in TRIUMPH Pivotal Trial with its Transcatheter Tricuspid Valve Replacement System
PLYMOUTH, Minn., Oct. 29, 2026 /PRNewswire/ -- Minnesota based Laplace Interventional today announced that the first three patients have been enrolled and treated in the randomized cohort of their TRIUMPH pivotal trial. These patients were treated at Ballad Health (Kingsport, TN) and...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.